As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
|Articles|December 9, 2022
News Roundup: December 5 to December 9
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Pharmacist Involvement Has Positive Impact on Patients Receiving Gender Affirming Care
Pharmacists can optimize medication adherence and serve as an additional touchpoint for patients during treatment.
Creating A Career Ladder for Pharmacy Technicians
Developing more advanced roles for pharmacy technician can reduce turnover in roles.
Representation Matters: Improving Diversity in Pharmacy
Ann Anaya and Dean Kathleen Kennedy discuss the importance of diversity in pharmacy and why it matters that patients are treated by someone who looks like them. Plus, Good Neighbor Pharmacy launches a scholarship program to help address these needs.
Pharmacist Intervention Improves Clinical Outcomes in Patients with Diabetes
Diabetes self-management education and diabetes prevention programs can improve patient outcomes including mental health and HbA1C.
Multidisciplinary Stakeholder Approach Successful in Managing Limited COVID-19 Treatment Resources
Two clinical pathways were created to manage patients and required resources.
Advertisement
Related to this article
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
Pennsylvania has become the center of the outbreak as cases exceed 775 alongside conflicting mortality reports.
The LATA trial found long-acting cabotegravir–rilpivirine is better than daily oral therapy at keeping adolescents virologically suppressed.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Mark Garofoli, PharmD, BCGP, CPE, CTTS, explains how to guide patients past crowded combination products, uncertain decongestants, and hidden risks in OTC aisles.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Advertisement
Advertisement
Trending on Drug Topics
1
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
2
FDA Approves Onswik Weekly Insulin for Adults With T2D
3
Study Finds Reduced Cardiovascular Risk With Hormone Therapy Initiation
4
Conflicting Measles Reports Perpetuate as Cases Continue to Rise
5